Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors
about
Enterovirus A71 DNA-Launched Infectious Clone as a Robust Reverse Genetic ToolCoupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virusKunjin virus replicon vaccine vectors induce protective CD8+ T-cell immunity.Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.Sindbis Virus Vectors Designed To Express a Foreign Protein as a Cleavable Component of the Viral Structural PolyproteinKunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine DevelopmentIncorporation of Tick-Borne Encephalitis Virus Replicons into Virus-Like Particles by a Packaging Cell LineDNA vaccine coding for the full-length infectious Kunjin virus RNA protects mice against the New York strain of West Nile virusDifferential Effects of Mutations in NS4B on West Nile Virus Replication and Inhibition of Interferon SignalingSelection and Analysis of Mutations in an Encephalomyocarditis Virus Internal Ribosome Entry Site That Improve the Efficiency of a Bicistronic Flavivirus ConstructSignificance in Replication of the Terminal Nucleotides of the Flavivirus GenomeRole of Nonstructural Protein NS2A in Flavivirus AssemblyHelices 2 and 3 of West Nile Virus Capsid Protein Are Dispensable for Assembly of Infectious VirionsAntigen-specific immunotherapy of cervical and ovarian cancerPerspectives for therapeutic HPV vaccine developmentInhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteinsEvaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells.Immunotherapy for cervical cancer: Research status and clinical potentialHeterologous gene expression from transmissible gastroenteritis virus replicon particles.Tetracycline-inducible packaging cell line for production of flavivirus replicon particlesA simplified positive-sense-RNA virus construction approach that enhances analysis throughput.A conserved peptide in West Nile virus NS4A protein contributes to proteolytic processing and is essential for replicationStructure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication.Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replicationTemperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.Strategies for DNA vaccine delivery.Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications.Cytoplasmic RNA viruses as potential vehicles for the delivery of therapeutic small RNAs.Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription.Immunologic treatments for precancerous lesions and uterine cervical cancer.Immunotherapy and targeted therapy for cervical cancer: an update.A highly pathogenic porcine reproductive and respiratory syndrome virus candidate vaccine based on Japanese encephalitis virus replicon system.Current state in the development of candidate therapeutic HPV vaccinesViral and Synthetic RNA Vector Technologies and Applications.Construction of yellow fever virus subgenomic replicons by yeast-based homologous recombination cloning technique.Systemic administration of naked DNA with targeting specificity to mammalian kidneys.Acquiring transgenic tobacco plants with insect resistance and glyphosate tolerance by fusion gene transformation.A Kunjin replicon vector encoding granulocyte macrophage colony-stimulating factor for intra-tumoral gene therapy.Generation of CTL responses using Kunjin replicon RNA.Therapeutic vaccines for high-risk HPV-associated diseases.
P2860
Q27468727-B98552B0-AA33-4323-A13C-BD88A3FB5BA8Q27469797-135FA96A-617D-415D-9EB5-5CDCA9D46847Q27472866-793C9750-0092-4FE6-B79B-F2F4B378082EQ27472910-E73E15D1-71D1-45D4-A8F4-12B3FE4C3482Q27473478-7CB7A246-AFB9-4992-81A9-6BB35470C5A1Q27477561-8DAC6907-489A-41EB-8015-ABFB263A795BQ27477708-207BB9F5-022C-40F7-9E44-67410EC06F93Q27480946-13D86DE8-5BA4-4AA9-BFE1-FD247212887EQ27484997-B734F71A-2CCA-434A-B475-9BE145DA82FAQ27485015-C1076548-AA99-4F1D-8BD8-BBA6B52B556FQ27485661-3A94A281-1ED8-4F06-9E1B-75DE21699B65Q27485896-87521779-979E-40EF-A3C3-739A219614DEQ27488390-7A576F6D-4C49-4D13-97F7-081D2D7DA3B0Q27488697-C2EFEECC-4F36-4F5B-A0E7-FF5AF130A268Q28069272-7F172B09-2AF2-4396-9104-8A2C0D94F684Q29620712-0A388A1E-16D2-431E-8908-D2F73BD8390AQ33719206-89B8A3D6-5E39-4B06-ABA1-0A7CEBC7868DQ34033763-51A726EC-CC91-4B64-BFC8-7A2808964BC4Q34328584-73ED61B2-63B5-4FB3-960F-69CFC6EF1E1CQ34552578-93DBF15F-64D4-470B-937C-D2F25481BB06Q34992142-C5A25FBD-9475-49E1-BB20-8A430C9995B3Q35362758-74009518-F98C-425F-A13A-C1509571F511Q35702678-78CEE410-5F46-4942-BA1D-757A892C62E2Q36092279-4A8752A0-512C-45DD-8127-B038B97778C7Q36192685-59CD03C1-FB69-412E-B47F-BF937B37C3FEQ36316818-766D2115-AF30-45AB-BD72-CEEE955B3890Q36377208-C94315F7-DFC5-419E-89BD-B313D2822F68Q36937406-03ADD958-5169-4790-A51C-0651E43D347BQ37596892-6F3077AD-26EE-4A43-9980-A86EEB75E393Q37703113-2636CD45-ED0E-4353-A1BF-91860B76B536Q38633525-F8ECD7CC-D2C0-4CF2-A02C-92E984976B57Q38663271-F5FFC92C-645D-4CE4-A51E-F07ADC8DEE5BQ38743922-F1253216-DC87-4164-9096-5816670E7A39Q38885624-7AEDEEF1-5BB4-4E53-87B7-7EA04D40CDC6Q40255532-727CE7F0-3EBF-4921-8637-95B634D8F876Q40472167-36E96E60-63CA-448C-988F-43BB4DB6EE2CQ42012467-50FF6D17-5363-4904-8C08-B71670BD9292Q42983982-2FE94C0C-9A33-4BBF-ABCA-80994886E64CQ43041900-CD2088ED-7168-4326-952D-F90B64B0C3A0Q47255618-2502B4E4-4351-4579-9005-CBFA461A75A0
P2860
Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Stable high-level expression o ...... Kunjin virus replicon vectors
@ast
Stable high-level expression o ...... Kunjin virus replicon vectors
@en
Stable high-level expression o ...... Kunjin virus replicon vectors
@nl
type
label
Stable high-level expression o ...... Kunjin virus replicon vectors
@ast
Stable high-level expression o ...... Kunjin virus replicon vectors
@en
Stable high-level expression o ...... Kunjin virus replicon vectors
@nl
prefLabel
Stable high-level expression o ...... Kunjin virus replicon vectors
@ast
Stable high-level expression o ...... Kunjin virus replicon vectors
@en
Stable high-level expression o ...... Kunjin virus replicon vectors
@nl
P2860
P3181
P1433
P1476
Stable high-level expression o ...... Kunjin virus replicon vectors
@en
P2093
A N Varnavski
P2860
P304
P3181
P356
10.1128/JVI.74.9.4394-4403.2000
P577
2000-05-01T00:00:00Z